Menu Menu

National Clinical Evidence Taskforce Funding Update

15 December, 2022

Earlier this week the National Clinical Evidence Taskforce was informed that the Commonwealth Department of Health and Aged Care will not be continuing our contract to develop clinical guidelines for COVID-19 beyond December 31, 2022.

As a collaboration of 35 member organisations, we are extremely proud of our shared work over the last 33 months to ensure Australian clinicians have up-to-date, trustworthy, evidence-based guidance to support the best possible care for people with COVID-19.

Our 200+ clinicians and consumers have developed more than 200 recommendations and 22 flowcharts for the management and care of people with COVID-19 covering mild, moderate, severe and critical COVID-19, as well as care for people after COVID-19 and with long COVID.

Our guidance covers care in all settings including primary, acute and critical care, and all populations including paediatric and adolescent care; pregnancy and perinatal care; and care of older people and palliative care.

We believe up-to-date guidance to support clinicians caring for people with COVID-19 continues to be vital, especially at a time of rising cases and increasing pressure across the health system.

We thank our funders, partners, members and contributors for their ongoing support and are seeking alternative sources of funding to continue our work in 2023.


The National Clinical Evidence Taskforce is currently funded by:

  • Australian Government Department of Health and Aged Care for the development of the COVID-19 Guidelines
  • Walter Cottman Endowment Fund, managed by Equity Trustees for the development of the MPX Guidelines


Founding funders of the National COVID-19 Clinical Evidence Taskforce:

  • Australian Government Department of Health
  • Victorian Government Department of Health and Human Services
  • The Ian Potter Foundation
  • Walter Cottman Endowment Fund, managed by Equity Trustees
  • Lord Mayors’ Charitable Foundation


We’re supported by a number of national and international partners:

  • School of Public Health and Preventive Medicine, Monash University
  • Cochrane
  • Consumers Health Forum of Australia
  • Australian Commission on Safety and Quality in Health Care
  • Australian Living Evidence Consortium
  • Covidence
  • MAGICapp
  • NPS MedicineWise